KZR – kezar life sciences, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KZR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/25

08:00 am

kzr

Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter and Year End 2024 Financial Results [Yahoo! Finance]

Medium Report

Report

3/25

07:30 am

kzr

Medium Report

Report

3/24

08:29 am

kzr

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025 [Yahoo! Finance]

Medium Report

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025 [Yahoo! Finance]

Report

3/24

08:00 am

kzr

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025

Medium Report

Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025

Report

2/28

12:30 pm

kzr

Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "outperform" rating re-affirmed by analysts at William Blair.

Low Report

Kezar Life Sciences, Inc. (NASDAQ: KZR) had its "outperform" rating re-affirmed by analysts at William Blair.

Report

2/18

04:41 pm

kzr

Kezar Life Sciences to Present at Virtual KOL Event Hosted by William Blair on Zetomipzomib Clinical Development in Autoimmune Hepatitis and Provide a Safety Update from the PALIZADE Trial for Lupus Nephritis on February 27, 2025 [Yahoo! Finance]

Medium Report

Report

2/18

04:01 pm

kzr

Medium Report

Report

2/5

05:46 pm

kzr

Kezar Life Sciences files for $400M mixed securities shelf [Seeking Alpha]

Medium Report

Kezar Life Sciences files for $400M mixed securities shelf [Seeking Alpha]

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.